You just read:

Biomarck Announces Statistically Significant Results From the Phase 2 Controlled Clinical Study in Non Small Cell Lung Cancer (NSCLC)

News provided by

Biomarck Pharmaceutical, LTD

Jul 10, 2019, 08:37 ET